Detalles de la búsqueda
1.
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
Ann Hepatol
; 28(6): 101142, 2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468097
2.
An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
Diabet Med
; 39(6): e14799, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100462
3.
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.
BMC Health Serv Res
; 22(1): 487, 2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413987
Resultados
1 -
3
de 3
1
Próxima >
>>